Is it possible for lung cancer patients with pleural effusion to survive for 7 months?

The survival period of patients with metastatic pleural effusion varies. For example, if a patient has multiple metastases and is not actively treated, the survival period is only 3-9 months. If actively treated, the pleural effusion can be controlled, and some patients will not have pleural effusion recurrence. The survival period depends on the patient's control of lung cancer treatment. If the patient's lung cancer is well controlled, the survival period can reach more than two years, and even the patient will not have pleural effusion growth until death. Patients with lung cancer who have pleural effusion are very likely to survive for 7 months, and even up to 3-5 years. If there is an indication for surgery and there is no metastasis to the mediastinal lymph nodes, the 5-year survival rate is as high as 40%, or more.

Lung cancer targeted drug price list

There are many kinds of targeted drugs, such as anti-angiogenic drugs and epidermal growth factor receptor inhibitors for the treatment of lung cancer. Anti-lung cancer drugs such as sunitinib. The cost of targeted drugs for lung cancer patients varies according to the targeted drugs used. For patients using some EGFR inhibitors, it is recommended to use gefitinib or erlotinib, which costs about 1,500 yuan per month after reimbursement. For patients using the third-generation targeted drug anlotinib, the monthly cost is more than 6,000 yuan, and for patients using crizotinib with ALK mutations, the cost is more than 30,000 yuan per month, and it is not yet within the reimbursement range.

How long does a course of radiotherapy for lung cancer last?

If palliative radiotherapy is used for advanced lung cancer, it usually takes ten sessions, about two weeks, or some patients need twenty sessions, and a course of treatment can be completed in about a month. Lung cancer is divided into small cell lung cancer and non-small cell lung cancer. Radiotherapy and chemotherapy are divided into radical radiotherapy and chemotherapy, palliative radiotherapy and chemotherapy, and brain prevention radiotherapy and chemotherapy according to the purpose. The course of radiotherapy is generally about 30 times. If the patient is a more serious advanced lung cancer patient, it can be done about 50 times.